NC
DXCM icon

NZS Capital’s DexCom DXCM Stock Holding History

NZS Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-195,307
Closed -$27.1M – 59
2024
Q1 		$27.1M Buy
195,307
+23,665
+14% +$2.97M 1.12% 34
2023
Q4 		$21.3M Buy
171,642
+11,177
+7% +$1.14M 1.12% 33
2023
Q3 		$15M Buy
160,465
+33,818
+27% +$3.81M 0.81% 39
2023
Q2 		$16.3M Buy
126,647
+1,809
+1% +$219K 0.81% 38
2023
Q1 		$14.5M Buy
124,838
+74,045
+146% +$8.29M 0.77% 41
2022
Q4 		$5.75M Buy
50,793
+24,345
+92% +$2.67M 0.49% 46
2022
Q3 		$2.13M Buy
+26,448
New +$2.24M 0.2% 63

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NZS Capital's DXCM Position: Q2 2024 in Review

NZS Capital sold out of DexCom (DXCM) in Q2 2024, closing a stake of 195,307 shares — an estimated $27.1M sold.

NZS Capital first reported a position in DXCM in Q3 2022 and held it in 7 quarters. The position peaked at $27.1M in Q1 2024. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • NZS Capital reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • NZS Capital sold 195,307 DexCom shares in Q2 2024, an estimated $27.1M.
  • NZS Capital first reported a position in DexCom in Q3 2022 and held it in 7 quarters.
  • NZS Capital's DexCom position peaked at $27.1M in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on NZS Capital's 13F filing for Q2 2024, filed 14 Aug 2024.